Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,881 | -11,965 | -7,944 | -5,052 | -7,988 |
| Depreciation Amortization | 27 | 21 | 14 | 7 | 27 |
| Accounts receivable | 7,500 | 7,500 | 7,500 | 7,500 | -7,500 |
| Accounts payable and accrued liabilities | 478 | -774 | 716 | 477 | 299 |
| Other Working Capital | 1,876 | 2,167 | 4,389 | 6,730 | -4,644 |
| Other Operating Activity | -5,289 | -4,828 | -7,093 | -7,517 | 8,617 |
| Operating Cash Flow | $-10,289 | $-7,879 | $-2,418 | $2,146 | $-11,189 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -25 | -25 | -25 | -543 |
| Investing Cash Flow | $-25 | $-25 | $-25 | $-25 | $-543 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 11 | 11 | 11 | 11 | N/A |
| Common Stock Issued | 16,148 | 6,455 | 6,512 | 1,362 | 38,425 |
| Other Financing Activity | -132 | -132 | -132 | -132 | 0 |
| Financing Cash Flow | $16,027 | $6,335 | $6,391 | $1,242 | $38,425 |
| Beginning Cash Position | 32,627 | 32,627 | 32,627 | 32,627 | 5,934 |
| End Cash Position | 38,340 | 31,057 | 36,575 | 35,989 | 32,627 |
| Net Cash Flow | $5,713 | $-1,569 | $3,948 | $3,363 | $26,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,289 | -7,879 | -2,418 | 2,146 | -11,189 |
| Capital Expenditure | -25 | -25 | -25 | -25 | -543 |
| Free Cash Flow | -10,314 | -7,904 | -2,443 | 2,121 | -11,732 |